13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 35 holding rows worth $1,510,149,045.
- Accession
- 0001104659-26-062579
- Filer
- CIK 1425738
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 35 entries on the cover page, a total value of $1,510,149,045 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,510,149,045 with VALUE read as dollars as filed, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 9,066,621 | $445,715,088 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 673,505 | $173,979,812 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 4,164,120 | $135,583,747 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 5,558,885 | $121,572,815 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 7,732,808 | $119,858,524 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 14,549,768 | $80,605,715 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 15,470,502 | $58,014,383 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 4,368,804 | $36,610,578 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 5,539,724 | $35,620,425 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,237,659 | $29,493,414 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 1,459,599 | $29,425,516 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 688,036 | $26,482,506 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 8,253,316 | $24,759,948 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 521,117 | $17,363,618 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 7,964,188 | $15,968,197 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 12,872,946 | $15,447,535 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 262,674 | $15,274,493 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 2,011,895 | $14,485,644 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,153,256 | $13,527,468 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 491,654 | $12,311,016 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 2,164,777 | $11,408,375 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 491,340 | $10,264,093 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 173,859 | $9,821,295 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 261,508 | $8,295,034 | dollars as filed | |
| CERIBELL INC | 15678C102 | COMMON STOCK | 386,786 | $7,089,787 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 108,354 | $6,886,980 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 103,464 | $5,874,686 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 1,590,832 | $5,536,095 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 415,710 | $5,267,046 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 700,000 | $5,068,000 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 733,350 | $4,392,767 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 2,648,659 | $3,443,257 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC | 046513206 | COM NEW | 441,701 | $2,089,246 | dollars as filed | |
| AGOMAB THERAPEUTICS NV | 00860C102 | SPONSORED ADS | 156,250 | $1,639,063 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 772,126 | $972,879 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-062579 | this filing | 2026-05-15 | acceptance time not in the bulk data set |